SEI Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Sell
83,232
-110,956
-57% -$3.5M ﹤0.01% 1746
2026
Q1
$5.44M Buy
194,188
+120,554
+164% +$3.95M 0.01% 1476
2025
Q4
$2.76M Buy
73,634
+60,504
+461% +$1.99M ﹤0.01% 1686
2025
Q3
$362K Buy
13,130
+6,100
+87% +$210K ﹤0.01% 2385
2025
Q2
$222K Sell
7,030
-27,784
-80% -$894K ﹤0.01% 2521
2025
Q1
$1.16M Buy
+34,814
New +$1.25M ﹤0.01% 1853
2024
Q1
Sell
-9,779
Closed -$316K 2665
2023
Q4
$316K Sell
9,779
-33,132
-77% -$925K ﹤0.01% 2287
2023
Q3
$1.41M Sell
42,911
-36,273
-46% -$1.26M ﹤0.01% 1755
2023
Q2
$2.79M Sell
79,184
-11,940
-13% -$412K ﹤0.01% 1482
2023
Q1
$2.98M Buy
91,124
+22,984
+34% +$1.05M 0.01% 1437
2022
Q4
$3.75M Sell
68,140
-21,368
-24% -$1.17M 0.01% 1181
2022
Q3
$3.96M Buy
89,508
+19,121
+27% +$933K 0.01% 1202
2022
Q2
$3.46M Sell
70,387
-10,359
-13% -$466K 0.01% 1284
2022
Q1
$3.93M Buy
80,746
+22,852
+39% +$932K 0.01% 1232
2021
Q4
$2.47M Sell
57,894
-5,824
-9% -$232K ﹤0.01% 1500
2021
Q3
$2.44M Buy
+63,718
New +$2.05M 0.01% 1429

Other funds holding HRMY

SEI Investments's HRMY Position: Q2 2026 in Review

SEI Investments reduced its Harmony Biosciences (HRMY) stake by 57% in Q2 2026, selling an estimated $3.5M and leaving 83,232 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

SEI Investments first reported a position in HRMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $5.44M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • SEI Investments held 83,232 shares of Harmony Biosciences worth $3.03M as of Q2 2026.
  • SEI Investments sold 110,956 Harmony Biosciences shares in Q2 2026, an estimated $3.5M.
  • Harmony Biosciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1746 holding.
  • SEI Investments first reported a position in Harmony Biosciences in Q3 2021 and has held it in 16 quarters since.
  • SEI Investments's Harmony Biosciences position peaked at $5.44M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.